Oliver Zimmermann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Oliver Zimmermann has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Jan Torzewski
Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm
1 shared publicationMagdalena Bienek-Ziolkowski
Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm
1 shared publicationMatthias Kochs
Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm
1 shared publicationNico Merkle
Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm
1 shared publicationOlaf Grebe
Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm
1 shared publicationThorsten Nusser
Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm
1 shared publication
Latest Publications
- 20 February 2006
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 8 (2) , 162-166
Myocardial Biopsy Findings and Gadolinium Enhanced Cardiovascular Magnetic Resonance in Dilated Cardiomyopathy
Background: In some patients suffering from dilated cardiomyopathy (DCM) magnetic resonance imaging (MRI) shows late gadolinium enhancement with variable distribution. Myocardial biopsies in DCM reveal a chronic myocardial inflammatory process in almost 50% and myocardial persistence of adenoviral or enteroviral genome in about 15% of the patients. Aims: We prospectively investigated whether the pattern of late gadolinium enhancement correlates with myocardial biopsy findings. Methods and results: 42 patients with DCM and 42 control subjects underwent contrast MRI. In the DCM group, endomyocardial biopsies were performed and evaluated for inflammation and viral genome. None of the control subjects showed late gadolinium enhancement whereas in 29 DCM patients (69%) gadolinium enhancement was detectable (p<0.001). 21 of the DCM patients (50%) showed midwall septal enhancement, 7 patients (17%) showed a patchy distribution of hyperenhancement and 1 patient (2%) showed enhancement typical for ischemic heart disease. In myocardial biopsy analysis, 2 patients (5%) showed persistence of viral genome, 18 patients (43%) showed inflammation and in 22 patients (52%) neither virus nor inflammation was detected. The pattern of late gadolinium enhancement and myocardial biopsy findings were not significantly correlated (p=0.854). Conclusion: MRI as a non-invasive technique cannot replace myocardial biopsy for the differential diagnosis of DCM.
- 20 February 2006
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 8 (2) , 162-166
Myocardial Biopsy Findings and Gadolinium Enhanced Cardiovascular Magnetic Resonance in Dilated Cardiomyopathy
Background: In some patients suffering from dilated cardiomyopathy (DCM) magnetic resonance imaging (MRI) shows late gadolinium enhancement with variable distribution. Myocardial biopsies in DCM reveal a chronic myocardial inflammatory process in almost 50% and myocardial persistence of adenoviral or enteroviral genome in about 15% of the patients. Aims: We prospectively investigated whether the pattern of late gadolinium enhancement correlates with myocardial biopsy findings. Methods and results: 42 patients with DCM and 42 control subjects underwent contrast MRI. In the DCM group, endomyocardial biopsies were performed and evaluated for inflammation and viral genome. None of the control subjects showed late gadolinium enhancement whereas in 29 DCM patients (69%) gadolinium enhancement was detectable (p<0.001). 21 of the DCM patients (50%) showed midwall septal enhancement, 7 patients (17%) showed a patchy distribution of hyperenhancement and 1 patient (2%) showed enhancement typical for ischemic heart disease. In myocardial biopsy analysis, 2 patients (5%) showed persistence of viral genome, 18 patients (43%) showed inflammation and in 22 patients (52%) neither virus nor inflammation was detected. The pattern of late gadolinium enhancement and myocardial biopsy findings were not significantly correlated (p=0.854). Conclusion: MRI as a non-invasive technique cannot replace myocardial biopsy for the differential diagnosis of DCM.